Stockscreener 앱 받기
1.875
2.34%
-0.045
전일 마감가:
$1.92
열려 있는:
$1.93
하루 거래량:
43,709
Relative Volume:
0.11
시가총액:
$219.09M
수익:
-
순이익/손실:
$-13.73M
주가수익비율:
-14.42
EPS:
-0.13
순현금흐름:
$-3.92M
1주 성능:
-0.79%
1개월 성능:
-4.82%
6개월 성능:
+46.48%
1년 성능:
+100.04%
1일 변동 폭
$1.8531
$1.9506
1주일 범위
$1.78
$2.10
52주 변동 폭
$0.6295
$2.60
Tiziana Life Sciences Ltd Stock (TLSA) Company Profile
TLSA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TLSA
Tiziana Life Sciences Ltd
|
1.875 | 228.14M | 0 | -13.73M | -3.92M | -0.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
420.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
630.36 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.38 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
811.48 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
179.68 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-12-22 | 개시 | B. Riley Securities | Buy |
| 2018-12-17 | 개시 | Laidlaw | Buy |
Tiziana Life Sciences Ltd 주식(TLSA)의 최신 뉴스
Is Tiziana Life Sciences Ltd stock a buy before product launchesInsider Selling & Stock Portfolio Risk Management - newser.com
How Tiziana Life Sciences Ltd stock compares to industry benchmarksJuly 2025 Fed Impact & Verified Swing Trading Watchlist - newser.com
What technical signals suggest for Tiziana Life Sciences Ltd stockEarnings Risk Report & Consistent Growth Equity Picks - newser.com
Analyzing recovery setups for Tiziana Life Sciences Ltd investors2025 Trading Volume Trends & Safe Entry Trade Reports - newser.com
Will Tiziana Life Sciences Ltd stock recover faster than marketTrade Risk Assessment & Daily Volume Surge Signals - newser.com
Is Tiziana Life Sciences Ltd stock recession proof2025 Investor Takeaways & Safe Investment Capital Preservation Plans - newser.com
Is Tiziana Life Sciences Ltd stock entering bullish territoryEarnings Summary Report & Community Trade Idea Sharing - newser.com
Applying big data sentiment scoring on Tiziana Life Sciences LtdRate Cut & Verified Momentum Watchlists - newser.com
Can momentum traders help lift Tiziana Life Sciences LtdMarket Rally & Verified Momentum Stock Watchlist - newser.com
How to use a screener to detect Tiziana Life Sciences Ltd breakoutsMarket Activity Summary & Capital Efficiency Focused Strategies - newser.com
Will a bounce in Tiziana Life Sciences Ltd offer an exit2025 Risk Factors & High Win Rate Trade Alerts - newser.com
How to manage a losing position in Tiziana Life Sciences Ltd2025 Bull vs Bear & High Return Trade Opportunity Guides - newser.com
How Tiziana Life Sciences Ltd stock valuations compare to rivals2025 Trade Ideas & Free Accurate Trade Setup Notifications - newser.com
Can Tiziana Life Sciences Ltd stock outperform in 2025 bull marketWeekly Investment Report & Fast Gain Stock Tips - newser.com
Tiziana Life Sciences: Foralumab's Intranasal Push Is A Good Moonshot (NASDAQ:TLSA) - Seeking Alpha
Published on: 2025-10-31 05:15:32 - newser.com
Reversal indicators forming on Tiziana Life Sciences Ltd stockTrade Volume Report & Capital Efficiency Focused Strategies - newser.com
Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation Therapy - The Manila Times
Tiziana (Nasdaq: TLSA) to present at BIO-Europe on intranasal foralumab for na‑SPMS, MSA - Stock Titan
Tiziana Life Sciences to showcase intranasal foralumab at BIO-Europe 2025 - Proactive financial news
What hedge fund activity signals for Tiziana Life Sciences Ltd stockLong Setup & AI Forecasted Entry/Exit Points - newser.com
How Tiziana Life Sciences Ltd stock trades during market volatilityJuly 2025 PostEarnings & Risk Managed Investment Entry Signals - newser.com
Has Tiziana Life Sciences Ltd found a price floorPortfolio Gains Summary & Smart Allocation Stock Reports - newser.com
How supply chain issues affect Tiziana Life Sciences Ltd stock2025 Macro Impact & Free Real-Time Market Sentiment Alerts - fcp.pa.gov.br
Is Tiziana Life Sciences Ltd stock attractive after correctionJuly 2025 Breakouts & AI Powered Market Trend Analysis - newser.com
Tiziana Life Sciences Ltd (TLSA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.66%
0.84%
자본화:
|
볼륨(24시간):